Skin cancer patients to trial cancer vaccine
Patients with advanced skin cancer in England are set to access trials of a new cancer vaccine. The needle-free injection, which is given for up to two years, works by boosting the immune system’s response and helping it recognise, attack and remember cancer cells, to help stop the disease returning. The NHS has partnered with UK life-sciences company Scancell to widen access for patients at hospitals across the country, with seven sites initially registered and more to follow, and the first patients expected to be referred in May.